Meningococcal vaccines
Meningococcal vaccines include Meningococcal Group B (MenB),
Meningococcal C (MenC) and Quadrivalent Meningococcal ACWY (MenACWY)
vaccines. The majority of MenC and MenACWY vaccines used in clinical
practice contain modified diphtheria (CRM 197) or tetanus toxoid as
carrier. Hypersensitivity reactions following MenACWY or MenB vaccines
administration, including anaphylaxis, have been
reported43,44. Previous severe hypersensitivity
reactions to the vaccine or to its components, mainly tetanus or
diphtheria toxoid, are the only allergic contraindications to
Meningococcal vaccines.